Ocular histoplasmosis is a fungal infection that affects the eyes. It is caused by the fungus Histoplasma capsulatum, which is found in soil and bird droppings. Ocular histoplasmosis is a relatively rare condition, but it can cause significant vision loss if left untreated. In this article, we will take a closer look at the causes and treatment options for ocular histoplasmosis.
Ocular histoplasmosis (OH) is an infection of the eyes caused by the fungus Histoplasma capsulatum. The fungus is found in soil and bird droppings, and it is most commonly found in the Mississippi and Ohio River valleys. OH is a relatively rare condition, but it can cause significant vision loss if left untreated. OH is typically spread through airborne spores, which can be inhaled and then deposited in the lungs. The fungus can then spread to the eyes, where it can cause inflammation and damage to the retina and other parts of the eye. Symptoms of OH include blurred vision, floaters, and sensitivity to light. In some cases, OH can cause scarring of the retina, which can lead to permanent vision loss.
The primary cause of OH is exposure to the fungus Histoplasma capsulatum. This fungus is found in soil and bird droppings, and it is most commonly found in the Mississippi and Ohio River valleys. The fungus is spread through airborne spores, which can be inhaled and then deposited in the lungs. The fungus can then spread to the eyes, where it can cause inflammation and damage to the retina and other parts of the eye.
There are several factors that can increase the risk of developing OH. These include: • Living in or traveling to an area where the fungus is common • Exposure to bird droppings • Working in a profession that involves frequent exposure to soil or bird droppings • Having a weakened immune system
OH is typically diagnosed through a physical examination and a series of tests. The doctor may use a slit-lamp examination to look for signs of inflammation in the eyes. The doctor may also order a chest x-ray to check for signs of the fungus in the lungs. In some cases, a sample of fluid may be taken from the eye and examined under a microscope for signs of the fungus.
The primary treatment for OH is antifungal medication. The medication is typically taken orally for several weeks, and it can help to reduce the inflammation and clear up the infection. In some cases, a steroid may be prescribed to reduce inflammation in the eye. In severe cases of OH, surgery may be necessary to remove scar tissue from the retina. This can help to improve vision and prevent further damage. In some cases, laser treatment may be used to reduce the risk of vision loss.
Ocular histoplasmosis is a fungal infection of the eyes that can cause significant vision loss if left untreated. The primary cause of OH is exposure to the fungus Histoplasma capsulatum, which is found in soil and bird droppings. Risk factors for OH include living in or traveling to an area where the fungus is common, exposure to bird droppings, and having a weakened immune system. Treatment typically involves antifungal medication, and in some cases, surgery may be necessary to improve vision.
1.
Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients
2.
In-person and Virtual Palliative Care Are Both Beneficial for Advanced Lung Cancer Patients.
3.
Kidney cancer: Understanding what a renal cell carcinoma diagnosis means
4.
AI tool automates liver tumor detection and monitoring
5.
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
1.
Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection
2.
Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers
3.
Unlocking the Power of Cryoprecipitate: A Comprehensive Guide
4.
How Cancer Cells Evade Immune Destruction and the Fight Back
5.
Unlocking The Causes And Risk Factors Of Breast Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
2.
Current Scenario of Cancer- Q&A Session to Close the Gap
3.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation